Learn more at LeadIQ.com

Insights

New Chief Scientist CODA Biotherapeutics recently hired Susan Catalano as the chief scientific officer, bringing valuable expertise from her co-founding role at Cognition Therapeutics. This new addition could open doors for collaborations and partnerships with other biopharmaceutical companies.

Major Investment Injection With substantial investments totaling $28 million from notable firms like Versant Ventures, MPM Capital, and Pacira BioSciences, CODA Biotherapeutics is poised for significant growth. This influx of capital indicates a strong investor confidence in the company's innovative chemogenetic platform, presenting an opportunity for expansion and accelerated development.

Focus on Neurological Disorders CODA Biotherapeutics is targeting neurological disorders such as neuropathic pain and epilepsy with its gene therapy-mediated chemogenetic platform. By addressing unmet medical needs in these areas, the company can tap into a niche market and potentially establish itself as a key player in the neurology segment.

Successful Series A Funding Having raised $34 million in Series A financing in 2018, CODA Biotherapeutics demonstrated its ability to secure significant funding for its innovative biopharmaceutical solutions. This past success can be leveraged to attract new investors and partners, paving the way for further growth opportunities.

Strategic Investor Portfolio By having leading investors like Versant Ventures, MPM Capital, and Astellas Venture Management backing the company, CODA Biotherapeutics has built a strong network of support. Leveraging these strategic investor relationships can open doors to collaborations, joint ventures, and potential licensing agreements that could drive sales and market penetration.

Similar companies to CODA Biotherapeutics

CODA Biotherapeutics Tech Stack

CODA Biotherapeutics uses 8 technology products and services including Squarespace, Squarespace Commerce, Google Font API, and more. Explore CODA Biotherapeutics's tech stack below.

Squarespace
Content Management System
Squarespace Commerce
E-commerce
Google Font API
Font Scripts
Choices
Javascript Libraries
RSS
Miscellaneous
Webpack
Miscellaneous
Python
Programming Languages
Nginx
Web Servers

Media & News

CODA Biotherapeutics's Email Address Formats

CODA Biotherapeutics uses at least 1 format(s):

CODA Biotherapeutics Email Formats	Example	Percentage
FLast@codabiotherapeutics.com	JDoe@codabiotherapeutics.com	51%
Last@codabiotherapeutics.com	Doe@codabiotherapeutics.com	25%
First@codabiotherapeutics.com	John@codabiotherapeutics.com	20%
F.Last@codabiotherapeutics.com	J.Doe@codabiotherapeutics.com	4%

Frequently Asked Questions

Where is CODA Biotherapeutics's headquarters located?

CODA Biotherapeutics's main headquarters is located at 329 Oyster Point Boulevard, 3rd Floor South San Francisco, CA 94408 US. The company has employees across 2 continents, including North AmericaEurope.

What is CODA Biotherapeutics's phone number?

You can contact CODA Biotherapeutics's main corporate office by phone at

+1-925-285-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is CODA Biotherapeutics's official website and social media links?

CODA Biotherapeutics's official website is codabiotherapeutics.com and has social profiles on LinkedIn.

What is CODA Biotherapeutics's SIC code NAICS code?

CODA Biotherapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does CODA Biotherapeutics have currently?

As of October 2022, CODA Biotherapeutics has approximately 22 employees across 2 continents, including North AmericaEurope. Key team members include Senior Scientist: J. I.Senior Scientist Ii: S. M.Research Associate Ii: G. T.. Explore CODA Biotherapeutics's employee directory with LeadIQ.

What industry does CODA Biotherapeutics belong to?

CODA Biotherapeutics operates in the Biotechnology Research industry.

What technology does CODA Biotherapeutics use?

CODA Biotherapeutics's tech stack includes SquarespaceSquarespace CommerceGoogle Font APIChoicesRSSWebpackPythonNginx.

What is CODA Biotherapeutics's email format?

CODA Biotherapeutics's email format typically follows the pattern of . Find more CODA Biotherapeutics email formats with LeadIQ.

How much funding has CODA Biotherapeutics raised to date?

As of October 2022, CODA Biotherapeutics has raised $28M in funding. The last funding round occurred on Dec 02, 2021 for $28M.

CODA Biotherapeutics

CODA Biotherapeutics

Biotechnology ResearchCalifornia, United States11-50 Employees

CODA Biotherapeutics’ revolutionary chemogenetic platform aims to control the activity of cells to treat disease. With chemogenetics, the goal is to modify a target cell population using gene therapy to express a tunable “switch” protein. Cells modified with the “switch” can be activated or inactivated in a dose-dependent manner by a subsequently administered small molecule therapeutic, an effect that should only occur in the modified cells.

CODA’s engineered receptors will be able to modulate the activity of virtually any cell in which the receptor is ectopically expressed, making them suitable for the treatment of many disorders. CODA can further tailor the therapy to a particular disease by simply changing the viral capsid, DNA regulatory elements, and route of administration.

Company Overview

Headquarters: 329 Oyster Point Boulevard, 3rd Floor South San Francisco, CA 94408 US
Phone number: ✕
Access Insights for CODA Biotherapeutics and Millions of Other Companies
Sign up for full access to CODA Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-925-285-****
Website: codabiotherapeutics.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 11-50

Media & News

Funding & Financials

$28M
CODA Biotherapeutics has raised a total of $28M of funding over 5 rounds. Their latest funding round was raised on Dec 02, 2021 in the amount of $28M.

Funding & Financials

$28M
CODA Biotherapeutics has raised a total of $28M of funding over 5 rounds. Their latest funding round was raised on Dec 02, 2021 in the amount of $28M.

Company Leadership

J. I.
Senior Scientist
✕
Access Insights for CODA Biotherapeutics and Millions of Other Companies
Sign up for full access to CODA Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CODA Biotherapeutics and Millions of Other Companies
Sign up for full access to CODA Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. M.
Senior Scientist Ii
✕
Access Insights for CODA Biotherapeutics and Millions of Other Companies
Sign up for full access to CODA Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CODA Biotherapeutics and Millions of Other Companies
Sign up for full access to CODA Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
G. T.
Research Associate Ii
✕
Access Insights for CODA Biotherapeutics and Millions of Other Companies
Sign up for full access to CODA Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CODA Biotherapeutics and Millions of Other Companies
Sign up for full access to CODA Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. N.
Research Associate Iii
✕
Access Insights for CODA Biotherapeutics and Millions of Other Companies
Sign up for full access to CODA Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CODA Biotherapeutics and Millions of Other Companies
Sign up for full access to CODA Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.